Kenji Sugio Selected Research

Kenji Sugio Research Topics

Disease

68	Neoplasms (Cancer) 01/2022 - 01/2002
45	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 07/2002
39	Lung Neoplasms (Lung Cancer) 07/2021 - 01/2002
15	Neoplasm Metastasis (Metastasis) 12/2021 - 06/2002
13	Adenocarcinoma 01/2018 - 01/2002
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 05/2002
8	Carcinoma (Carcinomatosis) 09/2016 - 04/2003
6	Breast Neoplasms (Breast Cancer) 07/2020 - 08/2003
6	Adenocarcinoma of Lung 04/2019 - 01/2002
5	Disease Progression 01/2021 - 01/2005
3	Neoplasm Micrometastasis 11/2014 - 01/2002
3	Lymphoma (Lymphomas) 07/2014 - 08/2002
3	Carcinogenesis 03/2013 - 07/2005
3	Lymphatic Metastasis 08/2009 - 10/2006
3	Large Cell Carcinoma 03/2007 - 09/2005
3	Melanoma (Melanoma, Malignant) 04/2006 - 07/2002
3	Esophageal Neoplasms (Esophageal Cancer) 09/2005 - 05/2005
2	Thymoma (Thymic Carcinoma) 01/2020 - 03/2002
2	Febrile Neutropenia 01/2020 - 07/2016
2	Anemia 01/2020 - 10/2018
2	Brain Neoplasms (Brain Tumor) 04/2019 - 01/2009
2	Meningeal Carcinomatosis 04/2019 - 01/2009
2	Malignant Mesothelioma 09/2016 - 07/2009
2	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 06/2002
2	Pleural Effusion (Pleural Effusions) 03/2014 - 04/2003
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 07/2009 - 09/2007
2	Esophageal Squamous Cell Carcinoma 05/2009 - 07/2007
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2004 - 11/2003
1	Aggressive Fibromatosis (Desmoid) 01/2021
1	Fibroma (Fibromatosis) 01/2021

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 06/2018 - 04/2004
12	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2006
11	AntigensIBA 07/2009 - 03/2002
10	Gefitinib (Iressa)FDA Link 01/2022 - 01/2006
9	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2009
7	Pemetrexed (MTA)FDA Link 01/2022 - 09/2016
6	ParaffinIBA 01/2021 - 10/2004
6	Tyrosine Kinase InhibitorsIBA 01/2021 - 12/2006
6	Neoplasm Antigens (Tumor Antigens)IBA 09/2006 - 03/2002
5	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022 - 01/2020
5	osimertinibIBA 12/2021 - 05/2020
5	Biological ProductsIBA 08/2009 - 05/2003
5	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2008 - 03/2003
4	PlatinumIBA 01/2022 - 10/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2002
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2020 - 07/2007
4	Peptides (Polypeptides)IBA 03/2007 - 04/2004
4	Immunoglobulin G (IgG)IBA 09/2006 - 03/2002
4	Cadherins (E-Cadherin)IBA 01/2006 - 01/2002
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2020
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2020
3	S-1 plus cisplatinIBA 01/2020 - 11/2013
3	Pharmaceutical PreparationsIBA 04/2019 - 01/2007
3	Carcinoembryonic AntigenIBA 01/2016 - 03/2005
3	CateninsIBA 05/2009 - 03/2002
3	Indicators and Reagents (Reagents)IBA 05/2009 - 12/2004
3	Estrogens (Estrogen)FDA Link 01/2009 - 07/2007
3	Histidine (L-Histidine)FDA Link 05/2006 - 04/2004
3	beta CateninIBA 01/2006 - 01/2002
3	Tumor Biomarkers (Tumor Markers)IBA 03/2005 - 01/2003
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2018
2	TegafurIBA 12/2020 - 11/2013
2	alectinibIBA 01/2020 - 01/2017
2	Bevacizumab (Avastin)FDA Link 04/2019 - 01/2019
2	B7-H1 AntigenIBA 06/2018 - 01/2018
2	CarcinogensIBA 01/2018 - 03/2003
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 07/2016
2	Phosphotransferases (Kinase)IBA 07/2014 - 01/2010
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 07/2014 - 01/2010
2	ProdrugsIBA 11/2013 - 01/2007
2	AsbestosIBA 07/2009 - 04/2003
2	AntibodiesIBA 07/2009 - 03/2002
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2009 - 01/2006
2	Aromatase (CYP19)IBA 01/2009 - 05/2008
2	Messenger RNA (mRNA)IBA 09/2007 - 08/2003
2	CytokinesIBA 07/2007 - 01/2002
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 05/2007 - 01/2007
2	CytochromesIBA 05/2007 - 03/2003
2	HLA-A24 AntigenIBA 03/2007 - 05/2005
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2007 - 03/2003
2	Cytochrome P-450 CYP3AIBA 01/2007 - 05/2005
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2007 - 03/2003
2	Complementary DNA (cDNA)IBA 09/2006 - 03/2002
2	PhytohemagglutininsIBA 05/2006 - 07/2005
2	Amino Acids FDA Link 05/2006 - 04/2004
2	alpha Catenin (alpha E-Catenin)IBA 01/2006 - 03/2002
2	Keratins (Keratin)IBA 07/2002 - 01/2002
1	Cell-Free Nucleic AcidsIBA 07/2021
1	Nucleic AcidsIBA 07/2021
1	Formaldehyde (Formol)FDA Link 01/2021

Therapy/Procedure

15	Therapeutics 01/2022 - 06/2002
13	Drug Therapy (Chemotherapy) 01/2022 - 05/2005
10	Radiotherapy 12/2021 - 01/2009
7	Adjuvant Chemotherapy 05/2022 - 11/2014
5	Immunotherapy 11/2007 - 07/2002
4	Chemoradiotherapy 11/2013 - 05/2010
2	Segmental Mastectomy (Lumpectomy) 11/2020 - 06/2002
2	Ventriculoperitoneal Shunt 12/2016 - 01/2009
2	Metastasectomy 01/2016 - 06/2002
2	Lymph Node Excision (Lymph Node Dissection) 12/2015 - 06/2002